BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30443869)

  • 1. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
    Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
    Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
    Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
    Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
    Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
    Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
    Boulière F; Crepel M; Bigot P; Pignot G; Bessede T; de la Taille A; Salomon L; Tostain J; Bellec L; Soulié M; Rischmann P; Bernhard JC; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Rigaud J; Bouchot O; Patard JJ
    Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
    Scosyrev E; Messing EM; Sylvester R; Campbell S; Van Poppel H
    Eur Urol; 2014 Feb; 65(2):372-7. PubMed ID: 23850254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
    Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
    J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.